Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Non-Current Deffered Revenue (2021 - 2025)

Biote (BTMD) has 5 years of Non-Current Deffered Revenue data on record, last reported at $1.2 million in Q3 2025.

  • For Q3 2025, Non-Current Deffered Revenue fell 23.08% year-over-year to $1.2 million; the TTM value through Sep 2025 reached $1.2 million, down 23.08%, while the annual FY2024 figure was $1.6 million, 17.47% up from the prior year.
  • Non-Current Deffered Revenue reached $1.2 million in Q3 2025 per BTMD's latest filing, down from $1.4 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $11.1 million in Q1 2021 and bottomed at $802000.0 in Q4 2021.
  • Average Non-Current Deffered Revenue over 5 years is $3.3 million, with a median of $1.4 million recorded in 2025.
  • Peak YoY movement for Non-Current Deffered Revenue: tumbled 92.32% in 2022, then skyrocketed 44.16% in 2024.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $802000.0 in 2021, then increased by 15.46% to $926000.0 in 2022, then soared by 42.76% to $1.3 million in 2023, then increased by 17.47% to $1.6 million in 2024, then fell by 20.61% to $1.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Deffered Revenue were $1.2 million in Q3 2025, $1.4 million in Q2 2025, and $1.4 million in Q1 2025.